Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aurora Spine (TSV: ASG )

0.2800 -0.0050 (-1.75%)
Streaming Delayed Price Updated: 9:38 AM EDT, Sep 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,000
Open 0.2800
Bid (Size) 0.2750 (65)
Ask (Size) 0.2900 (50)
Prev. Close 0.2850
Today's Range 0.2800 - 0.2800
52wk Range 0.2200 - 0.4650
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Aurora Spine to Host ZOOM Call with Alpha Wolf Trading CEO Tim Weintraut
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Corporation to Attend Latin America Pain Society (LAPS) Conference, Showcasing Innovations in Pain Management and Spine Care for Emerging Markets
From Aurora Spine Corporation
Via GlobeNewswire

Performance

YTD
-24.32%
-24.32%
1 Month
+5.66%
+5.66%
3 Month
-1.75%
-1.75%
6 Month
-16.42%
-16.42%
1 Year
-27.27%
-27.27%

More News

Read More
Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss First Quarter Fiscal Year 2024 Financial Results
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine’s Second Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent Office
From Aurora Spine Corporation
Via GlobeNewswire
The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating Tube
From Aurora Spine Corporation
Via GlobeNewswire
AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Announces Attendance at J.P. Morgan Healthcare Conference
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results
From Aurora Spine Corporation
Via GlobeNewswire
AURORA SPINE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Joint Fixation System
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Second Quarter Fiscal Year 2023 Financial Results
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Corporation Schedules Release of First Quarter Fiscal Year 2023 Financial Results and Conference Call
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal Year 2022 Financial Results and Conference Call
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine to Attend the American Association of Neurological Surgeons Annual Meeting
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Announces Initial Surgeries Conducted Using its SiLO TFX™ MIS Sacroiliac Joint Fixation System
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Announces Presentation on DEXA Technology at the American Association of Neurological Surgeons Annual Meeting
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Receives IRB Multi-Site Selection Approval for its DEXA-C™ Cervical Interbody System
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Receives IRB Approval To Commence Multicenter Study for its DEXA-C™ Cervical Interbody System
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Corporation Schedules Release of Third Quarter Fiscal Year 2022 Financial Results and Conference Call
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Corporation Announces Positive Interim Results from Clinical Study using ZIP™ MIS Interspinous Fusion System
From Aurora Spine Corporation
Via GlobeNewswire
Aurora Spine Corporation to Attend the North American Spine Society (NASS) Annual Meeting
From Aurora Spine Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.